Quick links:

Task Forces

Workshops

Cefic LRI

 Twitter

IYC2011



Latest publications:
Introducing ECETOC

ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals) was established in 1978 as a scientific, non-profit making, non-commercial association and counts as its members the leading companies with interests in the manufacture and use of chemicals. An independent organisation, ECETOC provides a scientific forum through which the extensive specialist expertise of manufacturers and users can be harnessed to research, evaluate, assess, and publish reviews on the ecotoxicology and toxicology of chemicals, biomaterials and pharmaceuticals.

ECETOC's main objective is to identify, evaluate, and through such knowledge help the industry to minimise any potentially adverse effects on human health and the environment that may arise from the manufacture and use of chemicals. To achieve this, ECETOC facilitates the networking of suitably qualified scientists from its member companies and co-operates in a scientific context with international agencies, government authorities and professional societies.

ECETOC is governed by a Board of Administration comprising up to 12 senior executives from member companies. The Board is responsible for the overall policy and finance of the organisation and appoints the members of the Scientific Committee which defines, manages and peer reviews the ECETOC work programme.

The outputs of its work programme are manifested as published reports, papers and specialised workshops. ECETOC also provides scientific representation of manufacturers and users of chemicals via presentations at specialist fora and takes a scientific role in the activities of international organisations and regulatory groups.

Purpose

ECETOC's purpose is to develop concepts, data and positions which underpin the use of scientific principles in the translation of policy into regulation in Europe: to enable the benefits of chemicals to be realised while protecting human health and the environment.

Values

ECETOC has strong values of science and integrity; it works by establishing objective positions and then moving forward, not backwards from a predetermined view.

Vision

ECETOC will be the partner of choice focusing and engaging industry expertise for the European Commission, ECHA, and EFSA in the development of practices and concepts based on science as policy becomes embodied in regulations.

Mission

To promote the use of good science in human and environmental risk assessment of chemicals, biomaterials and pharmaceuticals.

Approach

ECETOC pursues its vision and mission according to an issue-based science strategy that was launched in 2007 and revised in 2011. It is broken down into 10 science areas (see section entitled ‘Science Programme') that are grouped according to 5 main themes:
• Presence of chemicals in humans
• Presence of chemicals in the environment
• Effects in humans and ecosystems
• Methods
• Science of risk assessment

ECETOC code of practice

Toxicology of Chemicals

Toxicology is a scientific discipline involving the study of structure and mechanism related to the toxic effects of natural and chemical agents. Ecotoxicology is concerned with the study of toxic effects on ecosystems. Both disciplines are considered vital elements of the chemical industry's dedication to safety.

A central concept of toxicology is that effects are dose-dependent. The relationship between the dose needed to produce a toxic effect and the likely level of exposure determines whether there is a significant risk of harm. Scientists in industry and government are concerned to make sure that any exposure to chemicals is below the level which could cause damage to health of humans or wildlife. At the same time, the public benefits from the technologies and products produced by the chemical industry. Better understanding of toxicity, serves to benefit and protect both manufacturers and everyday users of chemicals.

ECETOC members collaborate on strategic initiatives such as scientific workshops or task forces, which typically publish their peer-reviewed end findings. Its initiatives look at the presence of chemicals in humans, in the environment, the effects of the chemicals, scientific methods for measuring the above, and the science of assessing the level of risk.

ECETOC also acts as the scientific representative of the chemical industry towards European agencies and competent authorities and collaborates with ECVAM in order to develop alternatives to animal testing methods which ensure the same level of chemical safety.

It supports the chemical industry's long-range research initiative with the selection, monitoring and sometimes carrying out of workshops and also organises workshops on behalf of the chemical industry for some societies of toxicology.

ECETOC played an important role in developing the technical guidance for manufacturers and users of chemicals implementing the REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) legislation in Europe. With concerns that re-evaluation of many chemicals for REACH compliance would significantly increase animal testing in mind, ECETOC also undertook initiatives to develop guidance on scientific methods to minimise this.

The overall goal of ECETOC and its collaborating scientists is to promote the most scientific approaches to evaluating the safety of chemical products. The intended outcome is a high level of confidence in the safety of chemical products.

Afton Chemical Corporation
Name : Afton Chemical Corporation
AkzoNobel
Name : AkzoNobel
Albemarle
Name : Albemarle
AstraZeneca
Name : AstraZeneca
BASF
Name : BASF
Bayer
Name : Bayer
BP
Name : BP
Cepsa
Name : Cepsa
Clariant
Name : Clariant
Colgate
Name : Colgate
Dow Chemical
Name : Dow Chemical
Dow Corning
Name : Dow Corning
DSM
Name : DSM
DuPont
Name : DuPont
Eni
Name : Eni
Evonik Industries
Name : Evonik Industries
ExxonMobil
Name : ExxonMobil
F. Hoffmann-La Roche
Name : F. Hoffmann-La Roche
Firmenich
Name : Firmenich
Givaudan
Name : Givaudan
GlaxoSmithKline
Name : GlaxoSmithKline
Henkel
Name : Henkel
Honeywell
Name : Honeywell
Huntsman
Name : Huntsman
Ineos ChlorVinyls
Name : Ineos ChlorVinyls
International Flavors & Fragrances
Name : International Flavors & Fragrances
Johnson & Johnson
Name : Johnson & Johnson
L'Oréal
Name : L'Oréal
Lucite
Name : Lucite
Merck
Name : Merck
NiPERA
Name : NiPERA
Pfizer
Name : Pfizer
Procter & Gamble
Name : Procter & Gamble
Reckitt Benckiser
Name : Reckitt Benckiser
Rhodia
Name : Rhodia
SC Johnson
Name : SC Johnson
Shell Chemicals
Name : Shell Chemicals
Solvay
Name : Solvay
Statoil
Name : Statoil
Syngenta
Name : Syngenta
Total
Name : Total
Unilever
Name : Unilever
Wacker
Name : Wacker
ECETOC’s approach

ECETOC believes that by identifying developing issues at their nascence, the chemicals industry will be better placed to undertake the appropriate scientific initiatives. An over-arching science strategy serves to guide ECETOC’s science programme and uses an issues, rather than activity-based approach.

What does it involve?

The premise of this strategy is that ECETOC plays an integral role in science in society. Its particular remit is to contribute objective scientific evidence to the debate about the role of chemicals in the causality of disease and assure the process of risk assessment of these chemicals.

It does so via the pursuit of the following 5 broad themes:

    Presence of chemicals in humans
    Presence of chemicals in the environment
    Effects on humans and ecosystems
    Methods
    Science of risk assessment.

This science strategy is also used as a basis for working with other stakeholders, such as academia, regulators, associations and international institutions to ensure that objective scientific evidence is used to provide the highest quality risk assessment of chemical products that minimises wherever possible the use of animals in testing.

2011 Revisions to the science strategy

The science strategy has served ECETOC well over the last years, and has been used as a guide for discussing our work programme within the Scientific Committee and with our Member Companies. Since then, new challenges have come up for the chemical industry, both on science and on the regulatory front. Issues are becoming increasingly more complex, but at the same time we are confronted with a diminishing resource of specialists in the industry that can address them. Therefore the Board and the Scientific Committee decided to review ECETOC's strategy, including the science strategy, at the 2010 Annual Technical Meeting.

Since then the ideas which the meeting produced have been developed by the Board and the Scientific Committee. These include new ways of using the scientific resources at ECETOC's disposal and ways to increase added value for members. The Strategic Science Areas concept has served us well and provided a focus for the Scientific Committee. It has allowed us to monitor the balance of our portfolio of activities and to ensure that areas which were identified as strategic were receiving sufficient attention. After three years in operation it was felt useful to reassess whether these SSA's were still appropriate.

As a result of this analysis, the following decisions were adopted:

  1. Sensitive sub-populations will no longer be a separate SSA as it is considered that the area where ECETOC has been most involved, children's health, is covered under reproductive health.
  2. Indoor air should also no longer be an SSA as we are unable to define clear activities for Task Forces.
  3. The SSA ‘omics should be merged into testing strategies, as it is now becoming integrated into more mainstream toxicology research, if not yet into any testing requirements.
  4. The two SSA's entitled ‘Biodiversity and Ecosystems' and ‘Science in Society' were considered important, but the ideas behind them were insufficiently concrete for them to be readily understood by the membership. Further work will be required to give substance to these concepts.

Accordingly, from May 2011, ECETOC pursues the following 10 strategic science areas:

Presence of chemicals in humans.

Chemicals in human tissue

Chemicals in human tissue
Objective:
Ensure that the results of biomonitoring studies are placed into appropriate context within risk assessment to human health.

Mixtures

Mixtures and co-exposure
Objective:
Contribute to the development of a pragmatic, realistic, and science-based framework for the risk assessment of chemical mixtures.

Presence of chemicals in the environment

Assessment of environmental fate and behaviour

Assessment of environmental fate and behaviour
Objective:
Develop the understanding of environmental processes that drive the fate and behaviour of chemicals and the role of these processes in risk assessment.

Effects in humans and ecosystems

Reproductive health

Reproductive health
Objective:
Ensure that the methods and the testing strategy to identify and characterise developmental and reproductive toxicants are appropriate and optimised.

Biodiversity and ecosystems

Biodiversity and ecosystems
Objective:
Identify the key science issues relevant to risk assessment of chemicals in the environment in a way that is relevant to the potential impact on biodiversity of aquatic and terrestrial ecosystems.

Methods

Integrated testing strategies Integrated testing strategies
Objective:
Contribute to a more effective approach to hazard and risk assessment. This should also support the further development and application of alternative approaches to hazard assessment, and thereby improve the workability of REACH. Good ITS approaches can reduce cost and use of animals while providing best quality data for the risk assessment process.
Risk assessment of nanomaterials

Risk assessment of nanomaterials
Objective:
Develop a series of approaches for addressing health and environmental effects of nanomaterials.

Science of risk assessment

Role of chemicals in the causality of disease

Role of chemicals in the causality of disease
Objective:
Put the presumed associations between chemicals in the environment and disease into their proper scientific perspective. The focus is particularly directed towards rigorous methodology in observational epidemiology.

Risk, hazard and precaution

Risk, hazard and precaution
Objective:
Take into account all available scientific tools to adequately characterise risk not only based on hazard characteristics but also on exposure data and dose-response considerations.

Science in society

Science in society
Objective:
Improve public confidence in the science of risk assessment and to promote its use in public policy actions. This includes the need to counter the perceptions of bias, vested interest and lack of quality assurance of industry generated data.

 

 Keep up to date with the latest from ECETOC the easy way:

 

 

 

Follow us on Twitter

 

RSS Press feed

 

Sign up below to receive
press releases by email

 

A Press Pack is available upon request from our Communications, Media and Web Manager, Ian Cummings.

Email: ian.cummings@ecetoc.org

Tel. +32 2 663 3817

Fax. + 32 2 675 3625

Press Releases

A full list of Press Releases can be found here; subscribe to our Twitter or RSS Press feeds above to be kept up to date with news from ECETOC, or register below to receive ECETOC Press Releases by e-mail:

Name*
Job title
Organisation*
E-mail*
Comments

After submitting this form, you will be re-directed to the ECETOC home page and a confirmation mail will be sent to the e-mail address that you have provided.

 

Click here for latest Press Releases:

 

Wikio